Literature DB >> 5969782

Theoretical formulation of sustained-release dosage forms.

J R Robinson, S P Eriksen.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5969782     DOI： 10.1002/jps.2600551118

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  10 in total

1.  Pharmacokinetic determinants in the design and evaluation of sustained-release dosage forms.

Authors:  H Boxenbaum
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

2.  A pharmacokinetic method for designing prolonged-release formulations--propoxyphene hydrochloride.

Authors:  B E Rodda; S M Chernish; J F Nash
Journal:  J Pharmacokinet Biopharm       Date:  1976-06

3.  Computer-aided dosage form design. II. Methods for defining a zero-order sustained-release delivery system of maximum formulating flexibility.

Authors:  T Y Lee; R E Notari
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

4.  Pharmacokinetics of oral extended-release dosage forms. I. Release kinetics, concentration, and absorbed fraction.

Authors:  F Y Liu; N C Sambol; R P Giannini; C Y Liu
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

Review 5.  Pharmacokinetic data processed by microcomputer for the formulation of optimal drug dosage form.

Authors:  J M Aiache; M Turlier; A Tanguy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Apr-Jun       Impact factor: 2.441

6.  The in vitro development of extended-release solid oral dosage forms.

Authors:  L J Leeson; D Adair; J Clevenger; N Chiang
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

7.  Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.

Authors:  Madiha Maboos; Rabia Ismail Yousuf; Muhammad Harris Shoaib; Iqbal Nasiri; Tazeen Hussain; Hafiza Fouzia Ahmed; Wajiha Iffat
Journal:  Lipids Health Dis       Date:  2018-06-09       Impact factor: 3.876

8.  Formulation and evaluation of floating matrix tablet of stavudine.

Authors:  Pankaj H Prajapati; Vijay V Nakum; Chhagan N Patel
Journal:  Int J Pharm Investig       Date:  2012-04

9.  Formulation and evaluation of fixed-dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release.

Authors:  Sanjay Dey; Sankha Chattopadhyay; Bhaskar Mazumder
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

10.  Design, Development and Optimization of S (-) Atenolol Floating Sustained Release Matrix Tablets Using Surface Response Methodology.

Authors:  P T Gunjal; M B Shinde; V S Gharge; S V Pimple; M K Gurjar; M N Shah
Journal:  Indian J Pharm Sci       Date:  2015 Sep-Oct       Impact factor: 0.975
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.